This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
ALECENSA 150 mg, gélule
Data updated: 2026-05-02
Available in:
🇩🇪🇬🇧🇫🇷
Form
—
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
ROCHE REGISTRATION (ALLEMAGNE) (FR)
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Source
BDPM_FR
(
ARTG
)
Adjuvant treatment of resected non-small cell lung cancer,Alecensa is indicated as adjuvant treatment in adult patients following tumour resection of anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) (tumours equal to or greater than 4 cm or node positive).,Treatment of metastatic NSCLC,Alecensa is indicated for the treatment of patients with ALK-positive, locally advanced or metastatic NSCLC.